关注
Mar Riveiro
Mar Riveiro
Liver Unit, Internal Medicine Department
在 vhebron.net 的电子邮件经过验证
标题
引用次数
引用次数
年份
Genomewide association study of severe Covid-19 with respiratory failure
Severe Covid-19 GWAS Group
New England Journal of Medicine 383 (16), 1522-1534, 2020
19402020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7482021
Factors associated with rates of HBsAg seroclearance in adults with chronic HBV infection: a systematic review and meta-analysis
YH Yeo, HJ Ho, HI Yang, TC Tseng, T Hosaka, HN Trinh, MS Kwak, ...
Gastroenterology 156 (3), 635-646. e9, 2019
2102019
Phylogenetic demonstration of hepatitis E infection transmitted by pork meat ingestion
M Riveiro-Barciela, B Mínguez, R Gironés, F Rodriguez-Frías, J Quer, ...
Journal of clinical gastroenterology 49 (2), 165-168, 2015
1222015
Efficacy of sofosbuvir and velpatasvir, with and without ribavirin, in patients with hepatitis C virus genotype 3 infection and cirrhosis
R Esteban, JA Pineda, JL Calleja, M Casado, M Rodríguez, J Turnes, ...
Gastroenterology 155 (4), 1120-1127. e4, 2018
1102018
Management of direct-acting antiviral agent failures
M Buti, M Riveiro-Barciela, R Esteban
Journal of Hepatology 63 (6), 1511-1522, 2015
932015
Effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in patients with chronic hepatitis C previously treated with DAAs
J Llaneras, M Riveiro-Barciela, S Lens, M Diago, A Cachero, ...
Journal of hepatology 71 (4), 666-672, 2019
902019
Effectiveness and safety of entecavir or tenofovir in a Spanish cohort of chronic hepatitis B patients: validation of the page-B score to predict hepatocellular carcinoma
M Riveiro-Barciela, D Tabernero, JL Calleja, S Lens, ML Manzano, ...
Digestive diseases and sciences 62, 784-793, 2017
752017
Detailed stratified GWAS analysis for severe COVID-19 in four European populations
F Degenhardt, D Ellinghaus, S Juzenas, J Lerga-Jaso, M Wendorff, ...
Human molecular genetics 31 (23), 3945-3966, 2022
71*2022
Cirrhosis, liver transplantation and HIV infection are risk factors associated with hepatitis E virus infection
M Riveiro-Barciela, M Buti, M Homs, I Campos-Varela, C Cantarell, ...
PloS one 9 (7), e103028, 2014
662014
Serum hepatitis B core-related antigen is more accurate than hepatitis B surface antigen to identify inactive carriers, regardless of hepatitis B virus genotype
M Riveiro-Barciela, M Bes, F Rodríguez-Frías, D Tabernero, A Ruiz, ...
Clinical Microbiology and Infection 23 (11), 860-867, 2017
652017
Long‐term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia
A Palom, S Rodríguez‐Tajes, CA Navascués, J García‐Samaniego, ...
Alimentary pharmacology & therapeutics 51 (1), 158-166, 2020
612020
Rapid liver and spleen stiffness improvement in compensated advanced chronic liver disease patients treated with oral antivirals
M Pons, B Santos, M Simón-Talero, M Ventura-Cots, M Riveiro-Barciela, ...
Therapeutic Advances in Gastroenterology 10 (8), 619-629, 2017
612017
Red blood cell transfusion‐transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report
M Riveiro‐Barciela, S Sauleda, J Quer, F Salvador, J Gregori, M Pirón, ...
Transfusion 57 (2), 244-247, 2017
582017
Effectiveness and safety of sofosbuvir‐based regimens plus an NS 5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real‐life cohort
S Alonso, M Riveiro‐Barciela, I Fernandez, D Rincón, Y Real, S Llerena, ...
Journal of viral hepatitis 24 (4), 304-311, 2017
572017
Incidences and determinants of functional cure during entecavir or tenofovir disoproxil fumarate for chronic hepatitis B
YC Hsu, ML Yeh, GLH Wong, CH Chen, CY Peng, M Buti, M Enomoto, ...
The Journal of infectious diseases 224 (11), 1890-1899, 2021
562021
Acute liver failure due to immune-mediated hepatitis successfully managed with plasma exchange: New settings call for new treatment strategies?
M Riveiro-Barciela, E Muñoz-Couselo, J Fernandez-Sojo, N Diaz-Mejia, ...
Journal of hepatology 70 (3), 564-566, 2019
562019
Impact of the COVID-19 pandemic on hepatitis B and C elimination: an EASL survey
LA Kondili, M Buti, M Riveiro-Barciela, M Maticic, F Negro, T Berg, A Craxì
JHEP Reports 4 (9), 100531, 2022
542022
Immune‐related hepatitis related to checkpoint inhibitors: Clinical and prognostic factors
M Riveiro‐Barciela, A Barreira‐Díaz, J Vidal‐González, ...
Liver International 40 (8), 1906-1916, 2020
542020
Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D
A Palom, A Rando-Segura, J Vico, B Pacín, E Vargas, A Barreira-Díaz, ...
JHEP Reports 4 (10), 100547, 2022
512022
系统目前无法执行此操作,请稍后再试。
文章 1–20